vs
Side-by-side financial comparison of Incyte (INCY) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× JBT Marel Corp). Incyte runs the higher net margin — 23.8% vs 5.3%, a 18.6% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 20.9%). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 10.4%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
INCY vs JBTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net Profit | $303.3M | $53.1M |
| Gross Margin | — | 34.5% |
| Operating Margin | 23.7% | 7.2% |
| Net Margin | 23.8% | 5.3% |
| Revenue YoY | 20.9% | 115.6% |
| Net Profit YoY | 91.7% | 858.6% |
| EPS (diluted) | $1.47 | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $1.0B | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.2B | $934.8M | ||
| Q1 25 | $1.1B | $854.1M | ||
| Q4 24 | $1.2B | $467.6M | ||
| Q3 24 | $1.1B | $453.8M | ||
| Q2 24 | $1.0B | $402.3M |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | $53.1M | ||
| Q3 25 | $424.2M | $66.0M | ||
| Q2 25 | $405.0M | $3.4M | ||
| Q1 25 | $158.2M | $-173.0M | ||
| Q4 24 | $201.2M | $-7.0M | ||
| Q3 24 | $106.5M | $38.9M | ||
| Q2 24 | $-444.6M | $30.7M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | 34.5% | ||
| Q3 25 | 92.8% | 35.9% | ||
| Q2 25 | 93.5% | 35.8% | ||
| Q1 25 | 93.0% | 34.2% | ||
| Q4 24 | 92.5% | 38.4% | ||
| Q3 24 | 92.4% | 36.1% | ||
| Q2 24 | 92.7% | 35.6% |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 7.2% | ||
| Q3 25 | 32.5% | 10.2% | ||
| Q2 25 | 43.6% | 5.2% | ||
| Q1 25 | 19.5% | -3.9% | ||
| Q4 24 | 25.6% | 3.4% | ||
| Q3 24 | 12.8% | 10.3% | ||
| Q2 24 | -45.8% | 6.7% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | 5.3% | ||
| Q3 25 | 31.1% | 6.6% | ||
| Q2 25 | 33.3% | 0.4% | ||
| Q1 25 | 15.0% | -20.3% | ||
| Q4 24 | 17.1% | -1.5% | ||
| Q3 24 | 9.4% | 8.6% | ||
| Q2 24 | -42.6% | 7.6% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $1.04 | ||
| Q3 25 | $2.11 | $1.26 | ||
| Q2 25 | $2.04 | $0.07 | ||
| Q1 25 | $0.80 | $-3.35 | ||
| Q4 24 | $0.90 | $-0.22 | ||
| Q3 24 | $0.54 | $1.21 | ||
| Q2 24 | $-2.04 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $167.9M |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $5.6B | $4.5B |
| Total Assets | $7.3B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $167.9M | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $987.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $648.3M | ||
| Q2 24 | — | $647.7M |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $4.5B | ||
| Q3 25 | $4.7B | $4.4B | ||
| Q2 25 | $4.2B | $4.4B | ||
| Q1 25 | $3.7B | $4.1B | ||
| Q4 24 | $3.4B | $1.5B | ||
| Q3 24 | $3.2B | $1.6B | ||
| Q2 24 | $3.0B | $1.5B |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $8.2B | ||
| Q3 25 | $6.3B | $8.2B | ||
| Q2 25 | $5.8B | $8.3B | ||
| Q1 25 | $5.7B | $8.0B | ||
| Q4 24 | $5.4B | $3.4B | ||
| Q3 24 | $5.0B | $2.8B | ||
| Q2 24 | $4.7B | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $117.4M |
| Free Cash FlowOCF − Capex | — | $83.5M |
| FCF MarginFCF / Revenue | — | 8.3% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 2.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $117.4M | ||
| Q3 25 | $559.4M | $87.7M | ||
| Q2 25 | $44.7M | $102.2M | ||
| Q1 25 | $266.1M | $34.4M | ||
| Q4 24 | $381.2M | $128.7M | ||
| Q3 24 | $310.9M | $71.9M | ||
| Q2 24 | $-575.6M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $83.5M | ||
| Q3 25 | — | $56.5M | ||
| Q2 25 | — | $83.7M | ||
| Q1 25 | — | $14.4M | ||
| Q4 24 | — | $118.7M | ||
| Q3 24 | — | $65.0M | ||
| Q2 24 | — | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.3% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 25.4% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 2.21× | ||
| Q3 25 | 1.32× | 1.33× | ||
| Q2 25 | 0.11× | 30.06× | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 1.89× | — | ||
| Q3 24 | 2.92× | 1.85× | ||
| Q2 24 | — | 0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
